While these previous studies have focused on the role of cyclin D1 in rhabdoid tumors, our analyses shed new light on the functional diversity of distinct D-type cyclins and associated CDKs in ATRT to drive cell cycle progression and possibly response to CDK4/6 blockade. This evidence concerns the gene CCND1 and rhabdoid tumor.